NCT06485089View on ClinicalTrials.gov

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 14, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
ObesityBreast Cancer Risk
Interventions
DRUG

tirzepatide

Women taking tirzepatide as part of standard care in the Weight Managment Clinic

Trial Locations (2)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

66208

RECRUITING

University of Kansas Medical Center Breast Cancer Prevention Center, Westwood

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER